Off-Label Promotion, On-Targets Sales

被引：39

作者：

Fugh-Berman, Adriane ^{[1
]}

Melnick, Douglas ^{[1
]}

机构：

[1] Georgetown Univ, Med Ctr, Dept Physiol & Biophys, Washington, DC 20007 USA

来源：

PLOS MEDICINE | 2008年 / 5卷 / 10期

关键词：

D O I：

10.1371/journal.pmed.0050210

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1432 / 1435

页数：4

共 15 条

[1]

ARNOLD M, 2005, MED MARKET MEDIA, V11, P40

[2]

BAGHDADI R, 2007, RPM REPORT, V2, P1

[3] Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial [J].

Bresalier, RS ;

Sandler, RS ;

Quan, H ;

Bolognese, JA ;

Oxenius, B ;

Horgan, K ;

Lines, C ;

Riddell, R ;

Morton, D ;

Lanas, A ;

Konstam, MA ;

Baron, JA .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (11) :1092-1102

[4]

CINQUEGRANA J, 2006, LEGAL SHIFTING PERSP

[5] Off-label use of medicines: consensus recommendations for evaluating appropriateness [J].

Gazarian, Madlen ;

Kelly, Maria ;

McPhee, John R. ;

Graudins, Linda V. ;

Ward, Robyn L. ;

Campbell, Terence J. .

MEDICAL JOURNAL OF AUSTRALIA, 2006, 185 (10) :544-548

[6]

*GEN ACC OFF, 2001, GAO01286R, V8

[7] Drug therapy: Misoprostol and pregnancy. [J].

Goldberg, AB ;

Greenberg, MB ;

Darney, PD .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (01) :38-47

[8] Experts weigh in on promotion, prescription of off-label drugs [J].

Hampton, Tracy .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (07) :683-684

[9]

Muir H, 2006, NEW SCI, V191, P38

[10]

NILES S, 2006, MED AD NEWS, V12, P1

← 1 2 →